
Janssen Pharmaceuticals, a Johnson & Johnson company, has announced a development and commercialisation agreement with Sanofi for Janssen’s extraintestinal pathogenic …

A type of E. coli infection may increase a person’s chance of developing bowel cancer, according to a new study …

Antimicrobial resistance (AMR) could be tackled by giving people a combination of antibiotic drugs that are no longer effective on …
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour

